Schroder Investment Management Group
BIVV

Schroder Investment Management Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Schroder Investment Management Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-750
Closed -$40K – 1376
2017
Q4 		$40K Sell
750
-4,597
-86% -$252K ﹤0.01% 1283
2017
Q3 		$304K Hold
5,347
– – ﹤0.01% 1147
2017
Q2 		$323K Hold
5,347
– – ﹤0.01% 1111
2017
Q1 		$291K Buy
+5,347
New +$263K ﹤0.01% 1082

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Schroder Investment Management Group's BIVV Position: Q1 2018 in Review

Schroder Investment Management Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 750 shares — an estimated $40K sold.

Schroder Investment Management Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $323K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Schroder Investment Management Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Schroder Investment Management Group sold 750 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $40K.
  • Schroder Investment Management Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Schroder Investment Management Group's Bioverativ Inc. Common Stock position peaked at $323K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Schroder Investment Management Group's 13F filing for Q1 2018, filed 11 May 2018.